This website is for the U.S, for the other countries please refer to this link.
MenuMenuThe Advantage of Early Detection SUDOSCAN®: An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy. About SUDOSCAN
Small nerve damage can be reversible if detected early! The non-invasive medical device SUDOSCANis a highly sensitive and reproducible tool for the early detection of peripheral neuropathy. Early detecting and follow-up of peripheral neuropathy could help monitor disease progression and assess treatment efficacy to improve patient management and control complications caused by diseases like diabetes.
Learn More“For us to improve nerve function and the quality of life of the individual, we had to do extensive measures: skin biopsy to look at nerve regeneration, nerve conduction studies to show enhancements of nerve conductions and quantitative sensory tests which have a wide variance. These tests are time consuming, laborious and full of error. Now, we have SUDOSCAN that can measure electrical conductance along with sweat gland function in only 2 minutes with instant results that are 75% sensitive, 98% specific and with less than 5% error*.” *Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new tool to detect diabetes risk. Br J Diabetes Vasc Dis 11:204-209.Aaron I. VinikMD, PhD, FCP, MACP, FACE
No patient preparation Results in 3 minutes Easy-to-read critical data points to help physicians reach a diagnosis
Non-invasive No fasting Easy to operate CE and FDA approvals
Reproducible quantitative results Independent from environmental conditions Backed by evidence-based research 150 peer-reviewed journals publications
WHY SUDOSCAN IS CHOSEN BY PHYSICIANS ?
Learn why Physicians use SUDOSCAN during the diagnostic evaluation of Small Fiber and Autonomic Neuropathy for the early detection of potentially treatable diseases. Discover why your patients will appreciate a non-invasive test to monitor their disease and treatment outcome.
Request More InfoSchedule a Demo
SUDOSCAN featured on the Discovery Channel Show – Innovations Series
Impeto Medical on Worldwide Business with Kathy Ireland
Successful Webinar “Management of autonomic dysfunction” – July 2021
July 16, 2021No CommentsRead More →
SUDOSCAN and COVID-19
February 15, 2021No CommentsRead More →
SUDOSCAN in Intradialytic hypotension
June 18, 2021No CommentsRead More →
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
Matt Cutts, a software engineer and former head of the web spam team at Google, stated back in 2012 that "spammy directories" are disregarded while those who "excercise editorial discretion" worth it.
Even though countless business directories litter the internet, they won't all offer a positive change. Don't take unneeded risks and suggest your website to one that Google loves!